Lithium, a potent GSK‐3β inhibitor with therapeutic potential for mood disorders, neurodegenerative diseases, and viral infections, faces challenges in clinical use due to its narrow therapeutic window and toxicity at high doses. The gene discussed is GSK3B; the disease is neurodegenerative disease.